RhumbLine Advisers’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$682K Sell
30,705
-198
-0.6% -$4.4K ﹤0.01% 2466
2025
Q1
$574K Buy
30,903
+826
+3% +$15.4K ﹤0.01% 2486
2024
Q4
$398K Buy
30,077
+1,111
+4% +$14.7K ﹤0.01% 2815
2024
Q3
$970K Sell
28,966
-749
-3% -$25.1K ﹤0.01% 2277
2024
Q2
$745K Buy
29,715
+525
+2% +$13.2K ﹤0.01% 2409
2024
Q1
$657K Sell
29,190
-203
-0.7% -$4.57K ﹤0.01% 2495
2023
Q4
$630K Sell
29,393
-808
-3% -$17.3K ﹤0.01% 2529
2023
Q3
$542K Sell
30,201
-191
-0.6% -$3.43K ﹤0.01% 2572
2023
Q2
$618K Sell
30,392
-3,082
-9% -$62.7K ﹤0.01% 2554
2023
Q1
$728K Buy
33,474
+343
+1% +$7.46K ﹤0.01% 2271
2022
Q4
$1.03M Buy
33,131
+499
+2% +$15.5K ﹤0.01% 2116
2022
Q3
$832K Buy
32,632
+2,035
+7% +$51.9K ﹤0.01% 2243
2022
Q2
$621K Buy
30,597
+4,895
+19% +$99.3K ﹤0.01% 2376
2022
Q1
$636K Sell
25,702
-4,635
-15% -$115K ﹤0.01% 2309
2021
Q4
$1.05M Sell
30,337
-310
-1% -$10.8K ﹤0.01% 2181
2021
Q3
$831K Buy
30,647
+460
+2% +$12.5K ﹤0.01% 2315
2021
Q2
$783K Sell
30,187
-6,752
-18% -$175K ﹤0.01% 2350
2021
Q1
$796K Sell
36,939
-2,185
-6% -$47.1K ﹤0.01% 2291
2020
Q4
$841K Buy
39,124
+3,287
+9% +$70.7K ﹤0.01% 2218
2020
Q3
$529K Sell
35,837
-5,819
-14% -$85.9K ﹤0.01% 2266
2020
Q2
$931K Buy
41,656
+7,731
+23% +$173K ﹤0.01% 2076
2020
Q1
$479K Buy
33,925
+622
+2% +$8.78K ﹤0.01% 2181
2019
Q4
$541K Buy
33,303
+288
+0.9% +$4.68K ﹤0.01% 2327
2019
Q3
$1.16M Buy
33,015
+351
+1% +$12.3K ﹤0.01% 1972
2019
Q2
$1.84M Buy
32,664
+4,623
+16% +$261K ﹤0.01% 1791
2019
Q1
$2.05M Sell
28,041
-140
-0.5% -$10.2K ﹤0.01% 1695
2018
Q4
$1.8M Buy
28,181
+11,001
+64% +$702K ﹤0.01% 1712
2018
Q3
$1.71M Sell
17,180
-1,062
-6% -$106K ﹤0.01% 1742
2018
Q2
$1.3M Buy
18,242
+1,180
+7% +$83.8K ﹤0.01% 1896
2018
Q1
$1.78M Buy
17,062
+999
+6% +$104K ﹤0.01% 1674
2017
Q4
$1.62M Buy
16,063
+5,583
+53% +$562K ﹤0.01% 1739
2017
Q3
$366K Buy
+10,480
New +$366K ﹤0.01% 2469